MALAT1 and mantle cell lymphoma: Yet, only Panobinostat has been investigated and it showed activity in patients with MCL; unfortunately however, the treatment led to severe thrombocytopenia [100], and it is intriguing whether MALAT1 could serve as an alternative therapeutic target.